Patents Assigned to Centre National de Recherche Scientfique
  • Pharmaceutical composition containing ezrin mutated on tyrosine 353
    Patent number: 6399584
    Abstract: The invention relates to a pharmaceutical composition containing an effective amount of ezrin mutated on tyrosine 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier, for use preferably in the prevention and/or treatment of tumors.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: June 4, 2002
    Assignees: Institute Curie, Centre National de Recherche Scientfique
    Inventors: Monique Arpin, Tiziana Crepaldi, Alexis Gautreau, Daniel Louvard